NexImmune, Inc. (NEXI) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 58 transactions totaling $6.1M, demonstrating a bullish sentiment with $6.0M in net insider flow. The most recent transaction on Jun 11, 2024 involved a purchase of 1 shares valued at $0.
No significant insider buying has been recorded for NEXI in the recent period.
No significant insider selling has been recorded for NEXI in the recent period.
Based on recent SEC filings, insider sentiment for NEXI is bullish with an Insider Alignment Score of 100/100 and a net flow of $6.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NexImmune, Inc. (NEXI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading NEXI stock, having executed 58 transactions in the past 90 days. The most active insider is Grant Verstandig (Executive), who has made 11 transactions totaling $4.2M.
Get notified when executives and directors at NEXI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | Jones Kristi | Executive | Purchase | 1 | $N/A | $0 | |
| Nov 22, 2023 | S. Roemer Alan | Executive | Sale | 3,992 | $1.94 | $7.7K | |
| Nov 21, 2023 | S. Roemer Alan | Executive | Sale | 3,833 | $2.16 | $8.3K | |
| Mar 30, 2023 | J. Barer Sol | Executive | Purchase | 400,000 | $0.41 | $164.0K | |
| Nov 26, 2022 | Jones Kristi | Executive | Award | 296,700 | $N/A | $0 | |
| Nov 22, 2022 | Oelke Mathias | Executive | Award | 126,100 | $N/A | $0 | |
| Nov 22, 2022 | Trainer John | Executive | Award | 125,200 | $N/A | $0 | |
| Nov 17, 2022 | J. Barer Sol | Executive | Purchase | 75,000 | $0.48 | $36.0K | |
| Nov 16, 2022 | J. Barer Sol | Executive | Purchase | 125,000 | $0.48 | $60.0K | |
| Jun 7, 2022 | Verstandig Grant | Executive | Purchase | 26,876 | $2.28 | $61.3K | |
| Jun 6, 2022 | Verstandig Grant | Executive | Purchase | 25,000 | $2.14 | $53.5K | |
| Jun 3, 2022 | Verstandig Grant | Executive | Purchase | 15,000 | $2.22 | $33.3K | |
| Jun 2, 2022 | J. Barer Sol | Executive | Purchase | 20,720 | $2.22 | $46.0K | |
| Jun 2, 2022 | Verstandig Grant | Executive | Purchase | 47,900 | $2.23 | $106.8K | |
| Jun 1, 2022 | J. Barer Sol | Executive | Purchase | 40,000 | $2.35 | $94.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 25 | $6.1M | 90.9% |
Exercise(M) | 9 | $593.1K | 8.9% |
Sale(S) | 2 | $16.0K | 0.2% |
Award(A) | 3 | $0 | 0.0% |
Conversion(C) | 19 | $0 | 0.0% |
Insiders at NexImmune, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 58 transactions totaling $6.1M in purchases versus $16.0K in sales, the net buying activity of $6.0M signals strong executive confidence. Grant Verstandig (Executive) leads the buying activity with $4.2M in transactions across all time.